Search - tctmd.com

Displaying 1 - 13 of 13

Sort: Relevancy | Date

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

L.A. McKeown

August 05, 2022

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Daily News

Recovered Paclitaxel PAD Data Shift the Mortality Picture

L.A. McKeown

May 14, 2020

News Daily News

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

L.A. McKeown

June 10, 2019

News Daily News

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

L.A. McKeown

March 15, 2019

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

L.A. McKeown

March 01, 2019

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

La Reestenosis Intracraneal Intra Stent acarrea un Mayor Riesgo de sufrir Episodios Isquémicos

Yael L. Maxwell

August 30, 2013

News Daily News

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Yael L. Maxwell

August 30, 2013

News Daily News

Endovascular Intervention Generally Safe in Elderly PAD Patients

June 20, 2011

Advertisement

Top Endovascular News of 2024

Scientific Statement Reviews Current Antithrombotic Options in PAD

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Recovered Paclitaxel PAD Data Shift the Mortality Picture

FDA Review Affirms Mortality Signal With Paclitaxel-Based Devices for PAD Ahead of Panel Meeting

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

La Reestenosis Intracraneal Intra Stent acarrea un Mayor Riesgo de sufrir Episodios Isquémicos

Intracranial In-Stent Restenosis Leads to Higher Risk of Recurrent Ischemic Events

Endovascular Intervention Generally Safe in Elderly PAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content